Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus
about
The influenza virus enigmaInjectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)Current and future antiviral therapy of severe seasonal and avian influenzaModeling human influenza infection in the laboratoryUsing the Ferret as an Animal Model for Investigating Influenza Antiviral EffectivenessA novel video tracking method to evaluate the effect of influenza infection and antiviral treatment on ferret activityEffect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferretsOseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study DesignNanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infectionImpact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugsOseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferretsWhat is the optimal therapy for patients with H5N1 influenza?The Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the Murine ModelCompetitive Fitness of Influenza B Viruses Possessing E119A and H274Y Neuraminidase Inhibitor Resistance-Associated Substitutions in FerretsUse of highly pathogenic avian influenza A(H5N1) gain-of-function studies for molecular-based surveillance and pandemic preparedness.Avian influenza A H5N1 virus: a continuous threat to humans.Avian influenza virus in pregnancy.DBA/2 mouse as an animal model for anti-influenza drug efficacy evaluation.Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir.Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact.The role of oseltamivir in the treatment and prevention of influenza in children.Cost-effectiveness of antiviral stockpiling and near-patient testing for potential influenza pandemic.Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) VirusesNeutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library.Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model.How I treat influenza in patients with hematologic malignancies.Oseltamivir in human avian influenza infection.Update on antivirals and vaccines for seasonal and potential pandemic use.Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus.Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferretsComparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir.Consequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir-resistant influenza A viruses.Pharmacokinetic-pharmacodynamic determinants of oseltamivir efficacy using data from phase 2 inoculation studies.Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in miceReduced sensitivity of influenza A (H5N1) to oseltamivirPathogenesis of Influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculationPhage displayed peptides to avian H5N1 virus distinguished the virus from other virusesCompetitive fitness of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model.Efficacy of repeated intravenous administration of peramivir against highly pathogenic avian influenza A (H5N1) virus in cynomolgus macaques.
P2860
Q24616614-EA37FD45-5424-4F44-91B4-C804ACA3FDA0Q24645944-2E76C47C-E131-436D-98F8-C337C4E43FB6Q24656164-86EF688B-A00E-4AA7-8DC6-479149D10BB7Q26781842-963677E3-A2DF-4FEA-A0DD-F3CC738C25D5Q27000668-49AAEB60-C438-4AEC-8869-4E0660BA20D1Q27312788-491B8822-CF8D-4830-8203-60832DFAFC31Q27314689-08BD4447-CD0D-4349-BAB1-3A38DE89B453Q27317735-F89B7422-7D4C-44A3-92B4-CF5012C46075Q28308105-F848B69F-5843-4B2B-A6AB-CD099A96E894Q28472846-C07F90FA-9D03-4A64-9E47-9242F8642DD2Q28474960-57D8675A-930C-4A75-B8F2-E7C2959456B0Q28475630-647D1401-1315-4A40-B96C-4FA33383CE03Q28547982-4C1CB353-B637-46B0-B5EE-8FDC06B2921FQ28553195-EBD87F56-0E6D-4BF9-9F0B-DB94FB7D172CQ30205712-E8C26529-9BCD-45C0-A73B-A5C778AC38CDQ30224462-9231C694-206E-412E-9CFA-2904B7BE9B5CQ30250287-8E358A33-80E3-49BF-B3A6-4F22EFF32C5DQ30357472-12FAE0B2-1E0C-4FE1-9E09-D255950B2A50Q30361125-2A717214-579B-44E5-9F08-8A6D6928FC2CQ30362700-FE74DBCC-C879-4333-AF95-D6A646B29830Q30364977-4D22B6CE-FA21-4CC5-B57F-EDAA50A7D603Q30367643-A937F974-7A3E-4CFB-8193-4B37E0F89E24Q30372421-D27822EA-EC0B-4D87-9E10-35B01BD26FB8Q30372987-7ED0C497-2291-479D-B3DA-F934118AEBC5Q30376004-2A09DA03-202D-42D7-9E8F-7876E0CCC62BQ30383456-695A16E6-F841-4824-B247-05804B2887DBQ30386487-5BDB6227-511C-428B-B9D3-9AF72B06138AQ30389265-F241D310-A0B2-4EBA-880A-0F5F4B06652CQ30389890-BF3E97A7-4A1A-448E-BD20-98DE68E296B7Q30392198-D7302DEA-8D4C-4DB6-B6F3-9AD8467FAA3BQ30403382-D6406421-22B4-4067-829B-E93E13EC5819Q30421991-03852427-0F7B-4AFF-AE19-86283E060FCBQ30425354-6C7E47B4-2D0B-4968-A237-F2DB6C267CAAQ30625335-E07834FB-95B3-4C88-8FF1-25CC4F805305Q33761451-81C60F07-9724-4CAD-A891-9D5541F62DACQ33800864-76059E2A-03CC-4750-853C-A069FEAA63B0Q33922699-8A740270-56F3-4C62-8B1F-FBD0AC2A629FQ34009244-84005B74-6CF9-4EE0-8948-DC36365E06AAQ34046111-DDA7B4C5-4E7E-4D05-AD5E-8004B7FADBDAQ34058036-E5C800D3-147E-497D-B3BA-AF34254F53A2
P2860
Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Efficacy of oseltamivir therap ...... clades of H5N1 influenza virus
@ast
Efficacy of oseltamivir therap ...... clades of H5N1 influenza virus
@en
type
label
Efficacy of oseltamivir therap ...... clades of H5N1 influenza virus
@ast
Efficacy of oseltamivir therap ...... clades of H5N1 influenza virus
@en
prefLabel
Efficacy of oseltamivir therap ...... clades of H5N1 influenza virus
@ast
Efficacy of oseltamivir therap ...... clades of H5N1 influenza virus
@en
P2093
P2860
P356
P1476
Efficacy of oseltamivir therap ...... clades of H5N1 influenza virus
@en
P2093
Alan Douglas
David A Boltz
Natalia A Ilyushina
Neziha Yilmaz
P2860
P304
P356
10.1128/AAC.01312-06
P407
P577
2007-02-12T00:00:00Z